As of June 19, 2025, Vitana-X Inc (VITX) reports a ROE (Return on Equity) of 119.16%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Vitana-X Inc's ROE (Return on Equity)
Over recent years, Vitana-X Inc's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2018-09-30 | 119.16% |
| 2017-09-30 | -1943015.40% |
| 2016-09-30 | -152.56% |
| 2015-09-30 | -46.83% |
| 2014-09-30 | -728.10% |
This fluctuation highlights how Vitana-X Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Vitana-X Inc's ROE (Return on Equity) to Peers
To better understand Vitana-X Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Vitana-X Inc (VITX) | 119.16% |
| Encounter Technologies Inc (ENTI) | 335.48% |
| Apotheca Biosciences Inc (CBDC) | 307.69% |
| DelphX Capital Markets Inc (DELX.V) | 184.45% |
| JPO Solutions Inc (MOPN) | 163.64% |
| Nascent Biotech Inc (NBIO) | 156.16% |
Compared to its competitors, Vitana-X Inc's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.